We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results
New

Senior Director, Product Communications

Alnylam Pharmaceuticals
United States, Massachusetts, Cambridge
675 West Kendall Street (Show on map)
Feb 26, 2025
This role is considered Hybrid.

Overview

Reporting to the Chief Corporate Communications Officer, this role will oversee our product communications function encompassing 4 globally marketed brands and 3 late-stage product candidates. This role's primary responsibility will be to serve as the communications head for our leading TTR franchise encompassing both our marketed products ONPATTRO and AMVUTTRA (80%), while also overseeing communications for the rare and late-stage pipeline portfolio.

This role will spearhead the development and execution of clinical data and regulatory milestones; congress and publication communications; scientific platform communications for lay audiences; unbranded awareness campaigns; and executive thought leadership campaigns.

The Senior Director will also oversee a team of product communications professionals.

A successful candidate will have the proven ability to effectively manage complex projects, work collaboratively with stakeholders and across functions, effectively network across the organization and communicate with senior leaders all within a fast moving environment.

Key Responsibilities

  • Develop and manage comprehensive global external communications strategy that advances business goals for the franchise.
  • Create and execute branded and unbranded disease state education campaigns.
  • Actively monitor the competitive landscape, ensure response readiness, and adapt communications strategies accordingly.
  • Drive the product and franchise strategy focusing specifically where communications can deliver value with clear and specific tactics.
  • Work cross-functionally to ensure alignment with brand strategies (commercial, medical, market access, communications, HEOR, R&D, etc.)
  • Working together with international to ensure consistency.
  • Oversee day-to-day management of Communications agency, including budget oversight.
  • Ability to think creatively and strategically to develop awareness campaigns and mobilize action.

Qualifications

  • Bachelor's degree in related field, advanced degree preferred.
  • 15+ years of work experience required, preferably in biotech, pharmaceuticals, or healthcare.
  • Proven experience crafting strategic campaigns, editorial content strategy, and development of thought leadership content.
  • Superior storytelling, writing and editing skills; strong oral communication skills and ability to convey complex ideas.
  • Possess a good working knowledge of the digital and social media landscape in engaging audiences, with the ability to deliver innovative approaches and plans within this growing and important space.
  • Ability to link communications plans and activities to busines results.
  • High levels of tact, passion for the employee experience, commitment, curiosity, fresh thinking, flexibility and a global perspective.
  • Ability to work independently and use sound judgment in decision-making, including setting and managing priorities and meeting competing deadlines.
  • Sound judgment and ability to maintain confidentiality.
  • Comfortable with accepting feedback and adapting to deliver the desired product.
  • Ability to interact with all levels of the company top to bottom, including most senior company management.
  • Meticulous attention to detail and commitment to high quality and timely work product.
  • Strong project management skills preferred. Experience managing vendors to execute on consulting work is preferred.

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.

>
Applied = 0

(web-b798c7cf6-sn5jf)